AbbVie Inc. (ABBV) capitalization

Current snapshot

Market Cap
$384.26B
1.77B shares × $217.49 · as of last filing 2026-03-31
Net Worth
-$6.66B
Stockholders' equity · 2026-03-31
Enterprise Value
$440.81B
Market cap + debt − cash
Net Debt
$56.55B
Debt $65.94B − Cash $9.39B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $405.11B
FY'24 2024-12-31 $315.06B
FY'23 2023-12-31 $274.76B
FY'22 2022-12-31 $287.34B
FY'21 2021-12-31 $240.61B
FY'20 2020-12-31 $179.26B
FY'19 2019-12-31 $131.39B
FY'18 2018-12-31 $142.53B
FY'17 2017-12-31 $155.03B
FY'16 2016-12-31 $102.13B
FY'15 2015-12-31 $96.98B
FY'14 2014-12-31 $105.36B
FY'13 2013-12-31 $84.71B
FY'13 2012-12-31
FY'13 2011-12-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $385.83B
Q4'25 2025-12-31 $404.01B
Q3'25 2025-09-30 $410.29B
Q2'25 2025-06-30 $328.73B
Q1'25 2025-03-31 $371.27B
Q4'24 2024-12-31 $313.70B
Q3'24 2024-09-30 $349.93B
Q2'24 2024-06-30 $303.76B
Q1'24 2024-03-31 $322.86B
Q4'23 2023-12-31 $273.75B
Q3'23 2023-09-30 $263.99B
Q2'23 2023-06-30 $238.61B
Q1'23 2023-03-31 $283.04B
Q4'22 2022-12-31 $285.95B
Q3'22 2022-09-30 $238.36B
Q2'22 2022-06-30 $272.01B
Q1'22 2022-03-31 $288.23B
Q4'21 2021-12-31 $239.49B
Q3'21 2021-09-30 $191.68B
Q2'21 2021-06-30 $200.05B
Q1'21 2021-03-31 $192.09B
Q4'20 2020-12-31 $189.21B
Q3'20 2020-09-30 $155.38B
Q2'20 2020-06-30 $161.70B
Q1'20 2020-03-31 $113.07B
Q4'19 2019-12-31 $130.96B
Q3'19 2019-09-30 $112.29B
Q2'19 2019-06-30 $107.92B
Q1'19 2019-03-31 $119.51B
Q4'18 2018-12-31 $135.99B
Q3'18 2018-09-30 $143.29B
Q2'18 2018-06-30 $145.65B
Q1'18 2018-03-31 $151.06B
Q4'17 2017-12-31 $153.57B
Q3'17 2017-09-30 $142.44B
Q2'17 2017-06-30 $116.02B
Q1'17 2017-03-31 $104.45B
Q4'16 2016-12-31 $99.81B
Q3'16 2016-09-30 $103.43B
Q2'16 2016-06-30 $101.04B
Q1'16 2016-03-31 $92.82B
Q4'15 2015-12-31 $95.45B
Q3'15 2015-09-30 $90.54B
Q2'15 2015-06-30 $109.72B
Q1'15 2015-03-31 $94.13B
Q4'14 2014-12-31 $104.30B
Q3'14 2014-09-30 $92.99B
Q2'14 2014-06-30 $90.76B
Q1'14 2014-03-31 $82.70B
Q4'13 2013-12-31 $83.89B
Q3'13 2013-09-30 $71.79B
Q2'13 2013-06-30 $66.52B
Q1'13 2013-03-31 $65.45B
Q4'13 2012-12-31
Q3'13 2012-09-30
Q2'13 2012-06-30
Q1'13 2012-03-31

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (ABBV CIK 0001551152), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

SENS

Senseonics Holdings, Inc.

BMRN

BioMarin Pharmaceutical Inc

IPAR

INTERPARFUMS, INC.